| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Dec 18, 2024 | Cardiff Oncology, Inc. | CFO | Buy | 91.3 | +7,716 | 12.86% | ✗ | $36.7K |
| Sep 16, 2022 | Sep 19, 2022 | Cardiff Oncology, Inc. | CFO | Buy | 91.3 | +30,000 | 100.00% | ✗ | $46.7K |
| Sep 10, 2021 | Sep 13, 2021 | Cardiff Oncology, Inc. | CFO | Buy | 95.0 | +30,000 | 100.00% | ✗ | $194K |
| Nov 10, 2020 | Nov 12, 2020 | Cidara Therapeutics, Inc. | CFO | Buy | 95.0 | +50,000 | 75.95% | ✗ | $100.7K |
| Sep 24, 2019 | Mar 23, 2020 | Cidara Therapeutics, Inc. | CFO | Buy | 95.0 | +30,000 | 100.00% | ✗ | $57.2K |
| Sep 24, 2019 | Sep 26, 2019 | Cidara Therapeutics, Inc. | CFO | Buy | 95.0 | +30,000 | 17.14% | ✗ | $57.2K |